Key Highlights

  • Cenntro (NASDAQ:CENN) fell 81.89% to USD 0.36, with no specific cause identified.
  • Abits Group (NASDAQ:ABTS) fell 65.00% to USD 0.37 on the day it announced AI hosting plans.
  • reAlpha Tech (NASDAQ:AIRE) fell 43.63% to USD 0.3766 after pricing a USD 1.75 million offering.
  • Haoxin Holdings (NASDAQ:HXHX) fell 30.93% to USD 0.1630 a day after a broker order notice.
  • Baird Medical Investment (NASDAQ:BDMD) fell 25.07% to USD 0.1034 after a China distribution deal.

Cenntro (NASDAQ:CENN) (down USD 1.63, 81.89%): A Collapse Without a Clear Trigger

Cenntro (NASDAQ:CENN) fell 81.89% to USD 0.36 in regular trading on November 3, 2026, from a Monday close of about USD 1.99 (calculated). The company name comes from a screen reading and should be verified. No announcement explaining a drop of this size was identified, so the cause is unconfirmed. The main backdrop is a sales agreement dated October 9, 2026 allowing up to USD 100 million of common stock to be offered over time.

On October 16, 2026 the shares closed near USD 3.03, a Market Value of about USD 7.4 million, so the program is many times the company's size. Full-year 2025 Revenue was USD 18.08 million, down about 42%. Further issuance carries clear dilution risk.

Abits Group (NASDAQ:ABTS) (down USD 0.6871, 65.00%): AI Hosting Plans Fail to Hold the Shares

Abits Group (NASDAQ:ABTS) fell 65.00% to USD 0.37 in regular trading on November 3, 2026, from a Monday close of about USD 1.06 (calculated). That day the company announced a strategy to pursue AI and high-performance computing hosting at existing U.S. facilities. It was a plan to evaluate, and the company has signed no definitive hosting agreements, so the cause of the decline was not confirmed.

Full-year 2025 revenue rose to USD 9.13 million from USD 6.71 million, while the net loss widened to USD 2.87 million. An F-1 registration statement had a notice of effectiveness dated November 2, 2026, but its purpose was not described, so any link to a share offering is unconfirmed. With a market value near USD 3.4 million, any new issuance would dilute holders.

reAlpha Tech (NASDAQ:AIRE) (down USD 0.2915, 43.63%): Offering Priced Well Below the Prior Close

reAlpha Tech (NASDAQ:AIRE) fell 43.63% to USD 0.3766 in regular trading on November 3, 2026, from a Monday close of about USD 0.668 (calculated). The trigger was a financing. The company priced 4,375,000 shares, or pre-funded warrants, at USD 0.40 each for about USD 1.75 million in gross proceeds, with closing expected on or about November 4, 2026.

This is the third financing in about three and a half months. Cash was USD 2.23 million at June 30, 2026, down from USD 7.78 million at December 31, 2025, and the six-month net loss was USD 7.39 million. The raise is smaller than the USD 5.55 million cash decline (calculated), so further Capital needs remain likely, and the filing flagged substantial doubt about going concern.

Haoxin Holdings (NASDAQ:HXHX) (down USD 0.0730, 30.93%): Broker Order Warning Weighs

Haoxin Holdings (NASDAQ:HXHX) fell 30.93% to USD 0.1630 in regular trading on November 3, 2026, from a close of about USD 0.2360 (calculated). A Shareholder update dated November 2, 2026 said some Brokers may require orders to go through a broker representative. The company does not control brokerage policies and did not link the notice to any price move, so the connection is an inference.

A release dated October 1, 2026 reported an agreement to purchase 200 electric tractor units for about USD 18.02 million. The risks are listing and dilution: a Nasdaq bid-price extension of 180 days was shown on July 24, 2026, and the company has described USD 1.2 million in convertible notes and a USD 30 million Equity line. The price would need to rise more than sixfold (calculated) to reach USD 1.00.

Baird Medical Investment (NASDAQ:BDMD) (down USD 0.0346, 25.07%): Selling Pressure After a Distribution Deal

Baird Medical Investment (NASDAQ:BDMD) fell 25.07% to USD 0.1034 in regular trading on November 3, 2026, from a Monday close of about USD 0.1380 (calculated). It follows a November 2, 2026 release about an agreement covering 19 key China markets, with an initial order of about RMB 6 million, or roughly USD 900,000. No announcement explaining the decline was identified.

First-half 2026 revenue rose 24.6% to USD 9.92 million. The risk is liquidity: cash and restricted cash was USD 289,083 on June 30, 2026, against a short-term Loan balance of USD 10.76 million,.

Where Things Stand

These five penny stocks fell for different reasons, but financing and listing pressure recur. Only reAlpha Tech (NASDAQ:AIRE) had a clear trigger in a priced offering, while Cenntro (NASDAQ:CENN), Abits Group (NASDAQ:ABTS), Haoxin Holdings (NASDAQ:HXHX) and Baird Medical Investment (NASDAQ:BDMD) fell without a confirmed cause. Watch whether Cenntro uses its sales agreement, whether Abits explains its F-1 filing and names an AI site or customer, the closing of the reAlpha offering, Haoxin's reverse split plans, and follow-on orders at Baird Medical.